96.02 0.00 (0.00%)
After hours: 4:36PM EDT
|Bid||96.00 x 800|
|Ask||96.00 x 900|
|Day's Range||95.03 - 97.50|
|52 Week Range||56.91 - 97.50|
|Beta (3Y Monthly)||0.81|
|PE Ratio (TTM)||99.19|
|Earnings Date||Oct 30, 2019 - Nov 4, 2019|
|Forward Dividend & Yield||0.80 (0.84%)|
|1y Target Est||97.60|
CONMED Corporation (CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 7, 2019 to all shareholders of record as of September 13, 2019. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology.
Higher revenues, solid segmental performance and strong adjusted gross margins benefit CONMED's (CNMD) Q2 earnings. However, high long-term debt remains a concern.
Conmed (CNMD) delivered earnings and revenue surprises of 5.66% and 2.22%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Could CONMED Corporation (NASDAQ:CNMD) be an attractive dividend share to own for the long haul? Investors are often...
Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.
Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.
CONMED Corporation (CNMD) today announced that it will report financial results for the second quarter of 2019 after the market close on Wednesday, July 31, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 844-889-7792 (domestic) or 661-378-9936 (international) and refer to the passcode 6992059.
Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.
The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...